OBJECTIVE: To clarify the effect of erythropoietin (EPO) on neurite outgrowth of the cultured retinal neurocytes, and investigate whether EPO might potentially be beneficial in protecting cultured retinal neurocytes suffering from glutamate-induced cytotoxity. METHODS: After the retinal neurocytes were cultured for 48 hours, the culture media was replaced with serum-free media, and the cultured retinal cells were exposed to 1.0 U/ml, 3.0 U/ml and 6.0 U/ml EPO for another 48 hours; then the cells were stained with Sudan Black B, and the neurite outgrowth of those cells were evaluated by an image-analysis system. After the retinal neurocytes were cultured for 48 hours, the cells were cultured in serum-free media containing 5 mM or 10 mM glutamate, and the cells were incubated in the presence or absence of Epo (1.0 U/ml, 3.0 U/ml, 6.0 U/ml respectively) for another 48 hours. The survival and apoptosis rates of those cells were estimated by MTT assay and fluorescein isothiocyanate (FITC)-annexin V/propidium Iodide (PI) flow cytometry respectively. RESULTS: EPO induced a stable improvement of neurite outgrowth of retinal neurocytes in a dose-dependent manner. Compared with the control group, the neurite outgrowth length increased to 162.8% at 6.0 U/ml EPO exposure. EPO had no any significant effect on the survival and apoptosis rates of the retinal neurocytes cultured in serum-free media, but it was beneficial in promoting the survival and decreasing the early and total apoptosis rates of the cultured retinal neurocytes suffering from glutamate-induced cytotoxicity. CONCLUSION: EPO had a significant biological effect on neurite outgrowth of the dissociated retinal neurocytes in vitro. EPO was beneficial in promoting the survival and decreasing the apoptosis rates of the cultured retinal neurocytes suffering from glutamate-induced cytotoxicity.
OBJECTIVE: To clarify the effect of erythropoietin (EPO) on neurite outgrowth of the cultured retinal neurocytes, and investigate whether EPO might potentially be beneficial in protecting cultured retinal neurocytes suffering from glutamate-induced cytotoxity. METHODS: After the retinal neurocytes were cultured for 48 hours, the culture media was replaced with serum-free media, and the cultured retinal cells were exposed to 1.0 U/ml, 3.0 U/ml and 6.0 U/ml EPO for another 48 hours; then the cells were stained with Sudan Black B, and the neurite outgrowth of those cells were evaluated by an image-analysis system. After the retinal neurocytes were cultured for 48 hours, the cells were cultured in serum-free media containing 5 mM or 10 mM glutamate, and the cells were incubated in the presence or absence of Epo (1.0 U/ml, 3.0 U/ml, 6.0 U/ml respectively) for another 48 hours. The survival and apoptosis rates of those cells were estimated by MTT assay and fluorescein isothiocyanate (FITC)-annexin V/propidium Iodide (PI) flow cytometry respectively. RESULTS:EPO induced a stable improvement of neurite outgrowth of retinal neurocytes in a dose-dependent manner. Compared with the control group, the neurite outgrowth length increased to 162.8% at 6.0 U/ml EPO exposure. EPO had no any significant effect on the survival and apoptosis rates of the retinal neurocytes cultured in serum-free media, but it was beneficial in promoting the survival and decreasing the early and total apoptosis rates of the cultured retinal neurocytes suffering from glutamate-induced cytotoxicity. CONCLUSION:EPO had a significant biological effect on neurite outgrowth of the dissociated retinal neurocytes in vitro. EPO was beneficial in promoting the survival and decreasing the apoptosis rates of the cultured retinal neurocytes suffering from glutamate-induced cytotoxicity.
Authors: G Calapai; M C Marciano; F Corica; A Allegra; A Parisi; N Frisina; A P Caputi; M Buemi Journal: Eur J Pharmacol Date: 2000-08-11 Impact factor: 4.432
Authors: A L Sirén; M Fratelli; M Brines; C Goemans; S Casagrande; P Lewczuk; S Keenan; C Gleiter; C Pasquali; A Capobianco; T Mennini; R Heumann; A Cerami; H Ehrenreich; P Ghezzi Journal: Proc Natl Acad Sci U S A Date: 2001-03-20 Impact factor: 11.205
Authors: H H Marti; R H Wenger; L A Rivas; U Straumann; M Digicaylioglu; V Henn; Y Yonekawa; C Bauer; M Gassmann Journal: Eur J Neurosci Date: 1996-04 Impact factor: 3.386
Authors: Ana Paula Resende; Beatriz Silva; Berta São Braz; Telmo Nunes; Lídia Gonçalves; Esmeralda Delgado Journal: Drug Deliv Transl Res Date: 2017-10 Impact factor: 4.617
Authors: Yohan van de Looij; Alexandra Chatagner; Charles Quairiaux; Rolf Gruetter; Petra S Hüppi; Stéphane V Sizonenko Journal: PLoS One Date: 2014-04-22 Impact factor: 3.240